Navigation Links
BioFlorida Selects Collexis' BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations
Date:12/1/2008

COLUMBIA, S.C., Dec. 1 /PRNewswire-FirstCall/ -- Collexis Holdings, Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today a partnership with BioFlorida, Inc., Florida's statewide bioscience association, to promote BiomedExperts.com to the association's 200+ membership base. Through the partnership, BiomedExperts.com will serve as the primary professional network for BioFlorida, helping to facilitate collaboration and advance scientific discovery among its member researchers.

BiomedExperts.com is the world's first literature-based professional social networking site that was pre-populated with more than 1.8 million expert profiles from PUBMED. The site allows scientists and researchers to directly connect with and explore their professional contacts, grow their networks and identify researchers with the expertise needed for future collaborations. With 60,000+ registered users worldwide, BiomedExperts.com provides user-friendly interfaces through which research collaborators can share data and network with 1,800 organizations and institutions from 137 countries, totaling more than 21 million connections made through the site.

"Meeting the demands of Florida's ever-growing bioscience industry can be quite a challenge. Collexis' BiomedExperts.com will assist us in overcoming issues associated with those challenges," said Russell Allen, BioFlorida's president & CEO. "Choosing BiomedExperts.com as our primary professional network will allow us to introduce our membership to BiomedExperts.com ever growing community. The network will enable our members to track the latest research in life sciences, and connect with leading industry experts."

"We are excited about this partnership with BioFlorida and its selection of BiomedExperts.com to further enable collaboration among its members," said Collexis CEO Bill Kirkland. "Collexis' technology will be a valuable asset to the association and its overall mission. Working together with BioFlorida, we will leverage their members' expertise in all areas of the bioscience industry to help advance research throughout Florida and beyond."

About BioFlorida, Inc.

BioFlorida is Florida's statewide trade association for the bioscience industry providing advocacy, business development and communications services for more than 200 member companies. Our mission is to be the voice of the bioscience industry and the advocate for our member organizations-both large and small. Bringing knowledge and resources to Florida's bioscience community, BioFlorida supports the health, agricultural and energy sectors of biotechnology as well as the pharmaceutical and medical technology fields. For more information, visit bioflorida.com .

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world's first pre-populated scientific social network for life science researchers, www.biomedexperts.com . Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com .

Forward-Looking Statements

Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with the company's collaboration with BioFlorida. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-KSB for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.


'/>"/>
SOURCE Collexis Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital
2. Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members
3. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
4. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
5. Battelle Selects Xie to Develop Biomarker Services
6. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
7. HealthEast Care System Selects Concuitys ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
8. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
9. diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test
10. BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
11. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
Breaking Biology Technology:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):